The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial...

Background: We propose using neighborhood characteristics as demand-related morbidity adjusters to improve prediction models such as the risk equalization model. Results: Since the neighborhood has no explicit ‘place’ in healthcare demand models, we have developed the “Neighborhood and...

We exploit a policy change in Sweden to estimate the effect of copayments on the demand for children's and adolescents' usage of medical care. To this end, we use population-wide registry data including detailed characteristics of individuals and their medical visits. We examine whether the...

This study assesses the impact of children’s health insurance programs on health care utilization and health care expenditures of children from 6 to 14 years old in Vietnam using four rounds of the Vietnam Household Living Standard Surveys from 2006 to 2012. We find a positive effect of both...

ad a tough time in Covid due to weak healthcare infrastructure. India is one of the developing countries that managed the health crisis with scarce resources but also provided relief to many countries. Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana provides health assurance cover of up to Rs....

This e-book is based on a Minor Research Project sponsored by the University Grants Commission (UGC), India. It investigates quality of life related issues especially about how the forest villagers and tea-plantation workers of Dooars region in North Bengal (West Bengal, India) are provided with...

A recent debate in the medical literature has arisen around the mortality effects of obesity. Whereas it has been argued that the obese die younger, the data that have become available do not immediately support this. This potentially undermines the hypothesis that modern life with its physical...

This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...

In this paper I examine the characteristics of adults who report on whether they have health care coverage and of people who say that they are unable to see a doctor over the preceding year because of the cost. I make use of a unique data set, the Behavioral Risk Factor Surveillance System, a...